WHO Releases Instructions on Chronic Low Back Pain

The World Health Organization (WHO) has issued its first-ever guidelines on managing chronic low back pain (LBP) in primary and community care settings, outlining which therapies to utilize and which to avoid during regular care. Low back pain is...

Bayer and Salus Optima Team up on AI-enabled Healthy Aging Journey

Salus Optima, a leading provider of AI-enabled digital health and wellness solutions, and Bayer's consumer health division have formed a strategic alliance to help people age well. The collaboration advances both firms' common goal of transforming...

Antengene's Xpovio Bags Approval in Macau to Treat Multiple Myeloma

Antengene Corporation Limited (Antengene) announced that the Macau Pharmaceutical Administration Bureau has approved a New Drug Application (NDA) for Xpovio (selinexor) in combination with dexamethasone (Xd) for the treatment of adult patients...

Neurocrine Biosciences Bags US FDA Nod Therapy Designation For Adrenal Hyperplasia

Neurocrine Biosciences, Inc. announced it received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for crinecerfont in congenital adrenal hyperplasia. "We are very pleased that the FDA granted Breakthrough Therapy...

First Light Diagnostics Bags US FDA Nod For Anthracis Toxin Test

First Light Diagnostics announced that the FDA has approved the SensiTox B. anthracis Toxin Test for sale in the United States. Because of the ease with which B. anthracis spreads and the severe mortality and morbidity associated with inhalation...

Coya Therapeutics and Dr. Reddy's Partner To Treat ALS

Dr. Reddy's Laboratories SA and Coya Therapeutics, Inc. announced on that they have engaged into a research and license agreement for COYA 302, an investigational combination medication for the treatment of Amyotrophic Lateral Sclerosis (ALS)...

Indoco Remedies Bags US FDA Tentative Nod For Canagliflozin Tablets

Indoco Remedies Ltd. reported the receipt of a provisional US FDA approval for an Abbreviated New Drug Application (ANDA) for canagliflozin tablets 100 mg and 300 mg, a generic equivalent of Janssen Pharmaceuticals, Inc.'s Reference Listed Drug...

Venus Remedies Secures Marketing Approval For Three Oncology Drugs

Venus Remedies, a pharmaceutical company, announced that three oncology medications have been approved for marketing in the Philippines and Saudi Arabia. The Panchkula-based business said in a statement that it has acquired regulatory permission...

Sun Pharma Subsidiary and Aclaris Therapeutics Inks Licensing Pact

As per exchange filing, Sun Pharmaceutical Industries Inc., a subsidiary of India's leading medicine manufacturer Sun Pharma, has entered into a licensing arrangement with Aclaris Therapeutics Inc. Based on the licensing agreement, Aclaris has...

Clarivate Widens Alliance with VeriSIM Life For Drug Development

Clarivate Plc, a worldwide leader in connecting people and companies to trusted knowledge to alter their environment, has announced the debut of the VeriSIM Life Translational Index on Cortellis Drug Discovery knowledge by Clarivate. Customers...

© 2025 India Pharma Outlook. All Rights Reserved.